Tiny Northwest Biotherapeutics aims to dominate brain cancer
[Reuters] – Ten years ago, cash-strapped biotechnology company Northwest Biotherapeutics Inc was down to three employees and one week from closing its doors when a financial backer came forward at the annual JP Morgan Healthcare Conference. By 2007, that more
View todays social media effects on ABBV
View the latest stocks trending across Twitter. Click to view dashboard